TP53 and glioblastoma: Our findings demonstrate the mechanism by which inhibition of Rho GTPases and actin polymerization promote efficient sensitization of GBM cells expressing wild-type p53 to treatment with IR, and they suggest these pathways as targets for the reversal of acquired radioresistance in GBM tumors, with the advantage of simultaneously addressing the high invasiveness of GBM cells.